Deerfield International Master Fund, L.P., 10% Owner at Vanda Pharmaceuticals Inc. (VNDA), sold 547,886 shares at $15.76 ($8.6M) on 2016-09-15, disclosed to the SEC on 2016-09-19.
Open-market sale of $8.6M VNDA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.76 | 58,997 | $930K | 10.8% |
| 2 | $15.76 | 62,791 | $990K | 11.5% |
| 3 | $15.76 | 79,915 | $1.3M | 14.7% |
| 4 | $15.62 | 87,858 | $1.4M | 16.0% |
| 5 | $15.62 | 93,506 | $1.5M | 17.0% |
| 6 | $15.62 | 119,008 |
| $1.9M |
| 21.7% |
| 7 | $15.53 | 3,857 | $60K | 0.7% |
| 8 | $15.53 | 4,910 | $76K | 0.9% |
| 9 | $15.58 | 37,044 | $577K | 6.7% |
| Total | $15.67 avg | 547,886 | $8.6M | 100% |
| Filing → |
| EHTH | SELL | 2016-06-08 | $488K | — | Filing → |
| ZFGN | BUY | 2016-02-17 | $177K | — | Filing → |
| XNPT | BUY | 2016-02-16 | $18.8M | — | Filing → |